title: Opana ER abuse and thrombotic thrombocytopenic purpura (TTP)-like illness: a rising risk factor in illicit drug users.
abstract: We report the case of a 22 year-old-woman who presented with upper extremity cellulitis secondary to an infiltration of illicit intravenous drug use. She confessed to the intravenous use of Opana ER (an extended release oral formulation of oxymorphone) which is an opioid drug approved only for oral use. She was found to have clinical evidence of profound thrombotic microangiopathy which resulted due to the intravenous use of Opana ER. She showed full clinical improvement after withholding drug and supportive clinical care. Recent report of Opana ER intravenous abuse was published from Tennessee county and has now been increasingly recognised as one of the causes of thrombocytopenia which mimicks clinically as thrombotic thrombocytopenic purpura. Physicians should be aware of this association as the lack of familiarity to this can pose serious management dilemmas for our patients (especially the polysubstance abusers).
authors.affiliation: Department of Internal Medicine, East Tennessee State University, Johnson City, Tennessee, USA.
authors.forename: Aaysha
authors.initials: A
authors.lastname: Kapila
authors.forename: Lovely
authors.initials: L
authors.lastname: Chhabra
authors.forename: Vinod K
authors.initials: VK
authors.lastname: Chaubey
authors.forename: Jeffery
authors.initials: J
authors.lastname: Summers
mesh_terms: D000701:Analgesics, Opioid / Q000009:adverse effects*; D005260:Female; D006801:Humans; D009293:Opioid-Related Disorders / Q000150:complications*; D010111:Oxymorphone / Q000009:adverse effects*; D011697:Purpura, Thrombotic Thrombocytopenic / Q000139:chemically induced / Q000175:diagnosis; D015819:Substance Abuse, Intravenous / Q000150:complications*; D057049:Thrombotic Microangiopathies / Q000139:chemically induced* / Q000175:diagnosis; D055815:Young Adult
chemical_list: D000701:Analgesics, Opioid; D010111:Oxymorphone